Cargando…
Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686202/ https://www.ncbi.nlm.nih.gov/pubmed/34953317 http://dx.doi.org/10.1016/j.thromres.2021.12.012 |
_version_ | 1784617969361354752 |
---|---|
author | Nielsen, Nathan D. Rollins-Raval, Marian A. Raval, Jay S. Thachil, Jecko |
author_facet | Nielsen, Nathan D. Rollins-Raval, Marian A. Raval, Jay S. Thachil, Jecko |
author_sort | Nielsen, Nathan D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8686202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86862022021-12-20 Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? Nielsen, Nathan D. Rollins-Raval, Marian A. Raval, Jay S. Thachil, Jecko Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2022-02 2021-12-20 /pmc/articles/PMC8686202/ /pubmed/34953317 http://dx.doi.org/10.1016/j.thromres.2021.12.012 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editors-in-Chief Nielsen, Nathan D. Rollins-Raval, Marian A. Raval, Jay S. Thachil, Jecko Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? |
title | Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? |
title_full | Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? |
title_fullStr | Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? |
title_full_unstemmed | Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? |
title_short | Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? |
title_sort | is it hyperfibrinolysis or fibrinolytic shutdown in severe covid-19? |
topic | Letter to the Editors-in-Chief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686202/ https://www.ncbi.nlm.nih.gov/pubmed/34953317 http://dx.doi.org/10.1016/j.thromres.2021.12.012 |
work_keys_str_mv | AT nielsennathand isithyperfibrinolysisorfibrinolyticshutdowninseverecovid19 AT rollinsravalmariana isithyperfibrinolysisorfibrinolyticshutdowninseverecovid19 AT ravaljays isithyperfibrinolysisorfibrinolyticshutdowninseverecovid19 AT thachiljecko isithyperfibrinolysisorfibrinolyticshutdowninseverecovid19 |